Previous studies showed that Gal-3 is correlated with T2DM prevalence and incidence, potentially via the inflammatory signaling cascade that causes β-cell fibrosis and hinders insulin secretion [51], and was also shown to be higher in patients with obesity in a study by Weighert et al. [49,52]. Here, INS is linked to obesity disorder.